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Glycine-arginine-alpha-ketoisocaporic acid calcium (GAKIC) is a product
advertised to increase muscular endurance during exercise via metabolic intervention.
Purpose: The purpose of this study was to determine the effect of GAKIC ingestion on
maximum strength and muscular endurance. Methods: Utilizing a double-blinded,
crossover design, participants completed an upper and lower body resistance exercise
protocol once using 11.2gs GAKIC, and the other with a placebo. Results: An increase
in maximum strength was observed in the 1RM portion of the lower body protocol phase
with statistical trends in the lower body TLV portion of testing. No significant
differences were found in upper body 1RM, upper body TLV, HR, BLa, and Glucose
between conditions. Conclusion: We concluded that in this protocol, GAKIC increased
maximum strength in the 1RM leg press exercise. Further research is encouraged in
resistance exercise.
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CHAPTER I
INTRODUCTION

For centuries, competitors have attempted to find an edge in their respective
sports. From blood doping in humans, to “milk shaking” in thoroughbreds, many
methods of improving endurance exercise have been explored.
Dietary fads and substances hoping to improve strength and endurance have been
around as early as 500-400 B.C. (Williams and Branch 2000). Historically, athletes
would consume animal products such as deer liver and lion hearts in efforts of gaining
speed and strength (Williams and Branch 2000). Substances that provide an athlete with
strength, power, and endurance gains on top of maximum training are called
pharmacological ergogenics (Williams and Branch 2000).
In the past few years, controversies have surfaced concerning the use of these
ergogenics among high school, college, and professional athletes. A study showed that
athletes using performance enhancing substances during high school years would likely
continue to use performance enhancing substances throughout post- high school years
(Dodge and Jaccard 2006).
Furthermore, a 1999 study surveyed the use of creatine among NCAA Division I
athletic programs across the United States. The results indicated that 68% of the
participants (806 total) have heard of creatine and 28% reported using creatine (LaBotz
1

and Smith 1999). The researchers also noted that creatine was widespread among men
but was minimal among women, and that they learned about the supplement primarily
from their peers (LaBotz and Smith 1999).
Also, author Tom Robinson (2008) highlighted the unveiling of the steroid
epidemic in professional baseball. He noted the temptations and motivations athletes face
when contemplating the use of performance enhancing substances, which included
increased participation longevity in the respected sport as well as individual and team
pentacles (Robinson 2008).
Some ergogenics, such as anabolic steroids, are banned in most sports (Kreider
2003). Others, such as glycine-arginine-alpha-ketoisocaproic acid (GAKIC) are fairly
new ergogenics and have not been thoroughly researched for their efficacy and safety.
There are only a few published studies that investigated the effects of GAKIC on
performance. These studies were done by using either cycling or an isokinetic
dynamometer as the exercise mode. Therefore, the purpose of this study was to test the
effects of the GAKIC supplement on muscular endurance during a selected resistance
protocol using bench and leg press exercise.

Significance of Study
Muscular strength and endurance are an essential part of competitive and
noncompetitive sporting activities. Many individuals search for ways to enhance their
training and performance via supplementation through various amino acid combinations.
Therefore, this study’s investigation will enrich the limited literature regarding the effects
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of GAKIC on muscular strength and endurance, as well as contribute to the current
scientific literature.

Statement of the Problem
Will the ingestion of GAKIC during an acute bout of resistance exercise enhance
maximal strength and muscular endurance during upper and lower body exercise?

Hypothesis
HO1: There was no significant difference in heart rate between the PL and
GAKIC treatments.
HO2: There was no difference in blood lactate measures between the PL and
GAKIC treatments.
HO3: There was no significant difference in blood glucose between the placebo
(PL) and GAKIC treatments.
HO4: There was no significant difference in upper body 1RM or relative muscular
endurance between the PL and GAKIC treatment.
HO5: There was no difference in lower body 1RM or relative muscular endurance
between the PL and GAKIC treatments.

Basic Assumptions
The following were basic assumptions for the study:
1. Participants did understand all directions given to them.
2. Participants did follow the directions given to them.
3

3. Subjects did not participate in any strenuous exercise training 48 hours prior to
testing.
4. Measurements were accurately performed on calibrated equipment.
5. Participants were non-supplement using participants.
6. Participants did perform the given exercise to volitional failure.

Limitations
The following were limitations of the study:
1. The investigators did not test the athletes for steroid use.
2. Due to each participant monitoring his food intake 48 hours prior to testing,
nutrient intake may not have been repeated correctly.
3.

With lactate measure being measured via peripheral stick, measurements may not
accurately reflect what was occurring in the muscle.

Delimitations
1. The participants were between 18 and 35 years of age.
2. The participants were recreationally trained lifters.
3. Participants that were selected had more than 6 months of consistent training at
the time of testing.

Definitions
1. Muscular Fatigue: a decrease in the force generation of a working muscle across
time.
4

2. Exhaustion or Failure: inability to complete one repetition due to muscular
fatigue.
3. One Repetition Maximum- Maximum amount of weight that can be lifted in one
single muscle exertion.
4. Relative Muscular Endurance- Maximum amount of repetitions that can be done
with a certain percentage of a one repetition maximum.
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CHAPTER II
REVIEW OF LITERATURE\

For centuries, competitors have attempted to find an edge in their respective
sports (Williams and Branch 2000). Many methods have been explored, with most tried
and true products banned from competition usage. Others, such as GAKIC are new to the
sports world and have not been thoroughly researched to establish repeated, trustworthy
gains in endurance performance. Muscular endurance is defined as the ability of muscle
groups to exert an external force for many repetitions or successive exertions (Robergs et
al. 2004). To understand and enhance muscular endurance, one must understand the
mechanism of muscular contraction and how energy is produced through the process of
aerobic and anaerobic metabolism. Some products improve endurance by buffering lactic
acid while others enhance energy production (Yunoki et al. 2007). The enhancement of
muscular endurance revolves on the true understanding of energy metabolism and its
contribution to muscular contraction and fatigue.

Aerobic and Anaerobic Metabolism
During exercise, the human body relies on numerous sources of energy, which are
converted and used through two main pathways (aerobic and anaerobic metabolism).

6

Aerobic metabolism produces energy through substrate oxidation and requires oxygen
(Koch and Britton 2008). This process can also be termed oxidative phosphorylation.
Anaerobic metabolism describes the partial oxidation of substrates into lactic acid
and this process produces significantly less ATP per unit mass of substrate compared to
aerobic metabolism (DeBerardinis et al. 2007). Anaerobic metabolism is the major
pathway that produces ATP at the onset of high intensity exercise or during endurance
exercise beyond the lactate threshold (Prebble, 2010). However, both aerobic and
anaerobic pathways are active during exercise and both contribute to ATP production
required for muscular contractions.

Muscle Contraction
Human exercise and locomotion is facilitated by muscular contraction. Many
scientists have regarded the sliding filament theory as the standard in understanding
biologically how muscular contraction takes place. A received impulse from the nervous
system makes contact with the sarcolema of the muscle and travels down the transverse
tubules until the impulse reaches the sarcoplasmic reticulum (Layzer 1990). From there,
calcium is released, which stimulates troponin to move tropomyosin, exposing the acting
binding sites (Astrand, et al. 2003). The actin head forms a bond with the myosin
filament called the “actomyosin” complex (Allen et al. 2005). The actin heads of these
complexes swivel, causing a decreased distance between H zones in the muscle tissue,
which in turn is labeled a “contraction” (Berchtold e. al. 2000). Adenosine triphosphate
(ATP) is not directly utilized in this process but is used to break the “rigor” bond of the
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actomyosin complex (Bottinelli et al. 1994). This release is essential to the strength and
reproductivity of the contraction (i.e. endurance).

Muscular Fatigue
The idea of muscular endurance revolves around the concept of prolonging the
onset of muscular fatigue. Muscular fatigue is defined as a decreased in force generation
over time (Zawieja, 1998). As stated with muscular contraction, it is essential that ATP
be present to disassociate the actomyosin rigor bond in order for the actin head to release
and reset for another bond. During intense exercise, metabolic by-products accumulate
(hydrogen ions, and inorganic phosphates) which interfere with actin-myosin interaction.
Macedo et al. (2009) stated the cause and effect relationship between lactic acid
acidosis and muscular fatigue had been established in literature, but through
experimentation, it was found that the theory of lactic acid build up and muscle fatigue to
be pedagogical, and that decreased time of the PCr system was a correlated with
decreased performance. The researchers concluded that “If there is acidosis, it may be
caused by the increase hydrolysis of ATP in this type of exercise and not by lactate
production” (Macedo et al. 2009).
Westerblad et al. (2006) noted findings from study on mammalian muscle that
inorganic phosphates, created from the breakdown of creatine phosphates, appeared to be
the major cause of muscular fatigue. It was observed in the early phases muscular fatigue
that increased concentrations of inorganic phosphates were related to fatigue-induced
changes sarcoplasmic reticulum calcium release and actomyosin cross-bridge function.
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Muscle fatigue tends to be constant throughout all ages in regards to quick bouts
of exercise. Rawson (2010) conducted a study testing the resistance to fatigue in older
adults during repeated sets of intermittent contractions. His results showed the older men,
ranging from ages 60-72 yrs had a greater fatigue resistance than the younger men,
ranging from ages 19-23, in five sets of isokinetic knee extension with 30 repetitions
(Rawson, 2010). The suggested theory of healthy aging muscle showing improved
muscular fatigue resistance could be a result of the changing of muscle types.

Muscle Fiber Types
When discussing muscular endurance, one must know and understand the
different muscle fiber types. Type I muscle fibers are often termed “slow-oxidative”
fibers due to their greater efficiency in utilizing oxygen and generating forces necessary
for endurance exercise (Lowell and Shulman 2005). Type IIx muscle fibers are termed
“fast twitch” fibers due to their ability to generate greater amounts of force than Type I
fibers. The greater amount of force is a result of Type IIx muscle fibers and the ATP
phosphocreatine system of energy (Raben et al. 2006).
Type IIA fibers contain characteristics both of Type I and Type IIX fibers. These
fibers utilize a combination of aerobic and anaerobic metabolism to produce ATP and
generate a moderate amount of force (Arany et al. 2006). Ratel et al. (2006) conducted a
study that suggested children resist muscular fatigue better than adult by having more and
faster oxidative pathways, thus preventing the buildup of metabolic by-products that can
inhibit performance. This study also noted that children’s muscular fatigue resistance
could be contributed to a lower recruitment of Type IIx, muscle fibers (Ratel et al. 2006).
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Even with the right fiber type and energy system, hormonal influence can enhance as
well as decline muscle performance during endurance exercise.

Heart Rate, Blood Lactate, and Blood Glucose Responses to Exercise
Any increase in energy expenditure will require rapid physiological adjustments
to accommodate for the demand of energy (McArdle et al. 2007). During exercise,
cardiac output increases to supply more oxygen rich blood to the working muscles and
aids in thermoregulation. Typically, stroke volume tends to plateau at 40% of heart rate
max, while heart rate tends to increase until its heart rate peak (Robbins 1999). Heart rate
max can be predicted by the age formula (220-age) while heart rate peak is found by
graded exercise testing (Myers and Gullestad 1998). Heart rate shows a linear increase in
response to exercise until peak heart rate in reached (Lauer et al. 1996).
Glucose is a molecule in which working skeletal muscles break down in order to
form ATP during aerobic and anaerobic metabolism (Simoes et al. 1999). Blood glucose
is replenished continuously during exercise of up to one hour by a three to fivefold
increase of glycogen from the liver (Ahlborg et al. 1974). During prolonged exercise, a
gradual fall of blood glucose was noticed, with glucose levels mimicking someone who
has fasted for 3 days (Ahlborg et al. 1974).
Lactate accumulation signifies the onset of prolonged anaerobic metabolism
(McArdle et al. 2007). Generally, blood lactate can be produced continually from red
blood cell energy metabolism not involving mitochondria and by limits caused by high,
glycolytic muscle enzyme activity. Studies have shown that lactate production in most
individuals are relatively the same, but lactate clearance is the overall beneficial effect of
10

endurance training (Donovan and Brooks 1983). Isotope tracer studies show that lactate
produced in fast twitch muscles is shuttled to other fast and slow twitch muscles for
conversion to pyruvate, which is converted to acetyl-CoA to be incorporated into the
citric acid cycle for aerobic metabolism (Brooks 2009).

Performance Enhancing Substances
Dietary fads and substances hoping to improve strength and endurance have been
around as early as 500-400 B.C. Historically, athletes would consume animal products
such as deer liver and lion heart in efforts of gaining speed and strength (Williams and
Branch 2000). Substances that provide an athlete with strength, power, and endurance
gains on top of maximum training are called pharmacological ergogenics (Williams and
Branch 2000).
The UK Sport 2005 Drug Free Survey reported the patterns of supplement used
by athletes such as creatine, vitamin C, whey protein, iron, caffeine, and ginseng (Pertrczi
et al. 2007). From 520 participants, the results showed that creatine was the most popular
substance and a third of participants used more than one substance for enhanced
endurance and training longevity (Pertrczi et. al 2007).
Sodium bicarbonate ingestion has also been regarded to increase endurance
exercise by providing an increased blood pH, offsetting the perceived acidosis effect on
fatigue (Wu, et al. 2010). Price and Simmons (2010) studied the effects of sodium
bicarbonate ingestion on high intensity intermittent running and subsequent performance.
The researchers concluded that sodium bicarbonate supplementation could result
metabolic alkalosis but had so significant improvements on performance. The researchers
11

suggested that individuals might respond differently to the supplement and recommended
further studies to take a more individualized approach (Price and Simmons 2010).

GAKIC
GAKIC is being touted as an ergogenic aid that delays the onset of muscular
fatigue. Performance gains are hypothesized to be realized during muscular endurance
types of test.

Components of GAKIC
The amino acids found in GAKIC are advertised to deliver a delay in the onset of
muscular fatigue, promoting sustained strength and endurance from active muscles when
used in combination. The first component by name, Glycine, is one of the non-essential
amino acids and is used to help create muscle tissue and convert glucose into energy
while aiding to prevent the breakdown of muscle by boosting the body’s levels of
creatine, the main energy source utilized during anaerobic metabolism (Chyun, &
Griminger, 1984). Glycine is also essential for a healthy, normally functioning digestive
system, helping regulate the synthesis of the bile acid used to digest fats (Chyun, &
Griminger, 1984).
Arginine (A) is an amino acid that aids in keeping the liver, skin, joints, and
muscles healthy (Hambrecht et.al 2000). Large concentrations of arginine are found in
the skin, and this amino acid plays a key role in the health of all the body’s connective
tissues, particularly the muscles. Arginine helps the body process both creatine and
nitrogen, substances used for muscle metabolism (Hambrecht et.al 2000) .
12

Ketoisocaporic acid’s (KI) use in GAKIC is to serve as a Leucine precursor
(Anthony et. Al. 1999). Leucine, an essential amino acid, works with the amino acids
isoleucine and valine to repair muscles, regulate blood sugar, and provide the body with
energy. Leucine, being so easily converted to glucose, helps to regulate blood sugar. A
Leucine deficiency produces symptoms similar to those of hypoglycemia, which may
include headaches, dizziness, fatigue, depression, confusion, and irritability. (Anthony et.
Al. 1999)
Calcium (C) is one of the most abundant minerals found throughout the body.
99% of the body's calcium supply is stored in the bones and teeth where it supports their
structure and function (Nilas, Chrisiansen, & Rodbro, 1984). Calcium is also an
important mineral utilized also in muscle contraction, where it is stored in the
sarcoplasmic reticulum for release in response to motor nerve stimulation (Layzer 1990).
Buford and Koch (2004) conducted research on GAKIC and its performance
improving effects in repeated cycle sprints. Ten male participants completed a doubleblinded, randomized exercise with a PL serving as the control performing two trial days
separated by one week. In this study, the participants were given 11.2 g of GAKIC or PL
that was consumed 45 minutes prior to testing. The testing consisted of five
supramaximal, 10-s cycle ergometer sprints separated by one-minute intervals. The
results of the study were a greater retention of mean power between the first and second
sprints with the GAKIC (-1+/-2 W) versus the PL treatment (-47+/-18 W). The data from
the study supports resistance of fatigue and a maintaining of power output from using the
GAKIC supplement.
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Stevens et al. (2000) also conducted research on the effects of GAKIC on human
muscle dynamic performance ranging from strength, work, and fatigue under acute, highintensity anaerobic isokinetic exercise. Using an isokinetic dynamometer, 13 participants’
prefatigue and postfatigue peak torque values were measured in the quadriceps femoris.
Based on a randomized, double-blind crossover repeated measure design study, an
isocaloric sucrose served as the control while GAKIC served as the experimental
variable.
The results showed Fatigue resistance index ({periexhaustion torque}/{baseline
peak torque}) as well as work taken at 0,5,and 15 minutes after measures were greater
than the values of the isocaloric PL (p<0.02). The mean resistance to fatigue was also
28% greater than the PL. Gains in overall muscle work associated with GAKIC use
resulted in 10.5 + 0.8% lbs of torque greater than the control and was sustained for at
least fifteen minutes. These results also support GAKIC’s ability to delay muscular
fatigue and maintain power output over a given period of time.
A more recent study investigated the effects of GAKIC on high-intensity cycling
bouts. Ten well-trained cyclists performed 10 supramaximal sprints of ten seconds with
rest periods of fifty seconds in between. 11.211.2 grams of GAKIC were used just as in
previous research along with a PL. Participants went through two different test sessions
with at least two familiarization trials prior to testing (Bies et al. 2011). The results of the
study show no significant differences in performance between the uses of GAKIC versus
the use of PL with the scientist concluding that in contrast to previous studies with
untrained participants, GAKIC had no significant effects in trained individuals (Bies et al.
2011).
14

CHAPTER III
METHODOLOGY

Participants
Eleven male participants ranging in age from 21 to 36 years were recruited for
this study. To qualify, the participants were required to have had a minimum of six
months of continuous strength training. Participants were free of any medical conditions,
which could have hindered their ability to perform the exercise protocol. Prior to
participating in the study, participants were required to complete a health history
questionnaire (see Appendix B) and signed a statement of informed consent (see
Appendix A). Participants were reported not using any anabolic steroids for one year
prior to participation in the investigation. All preliminary qualifying participants were
interviewed to determine any potential period of anabolic use, and those not meeting the
one-year criteria were eliminated from the investigation. The procedures outlined were
reviewed and approved by the Institutional Review Board at Mississippi State University
(see Appendix C).

Participant Evaluation
During the initial session participants were provided with an explanation of the
informed consent and research protocol. The informed consent was signed prior to any
15

evaluations on the participant. On day one, all anthropometric measurements were
determined. Participants’ standing height, body weight, and body fat percent were
assessed. Standing height and body weight were assessed using a Doctor’s scale
(Healthometer 402EXP). Participants removed their shoes and stood erect with their
hands down at their side in an erect position. Heels were placed together. The
measurement stick was placed at the center of the participants’ head on the highest point.
Participants were weighed in shorts without shoes. Body weights were measured in
kilograms. Body fat percentages were measured using BOD POD’s Gold Standard model
(Life Measurement Inc).

Experimental Protocol (Trial 2 & 3)
Each participant performed the trials a minimum of one week apart, in which the
experimental treatments, GAKIC or a PL, were randomly assigned and administered in a
double-blinded fashion. Upon arriving to the Sanderson Center weight room, the
participants were taken to a designated area for 5 minutes of quiet rest. Next, the
participant’s heart rate (HR), glucose (GLU) and resting blood lactate levels (BLa) were
measured. HR and BPwas assessed using an automated blood pressure monitor
(SunTech Medical Cycle). BLa was assessed by taking blood samples from the finger
sticks from the participants and samples were immediately analyzed using the Lactate Pro
Analyzer. GLU was assessed using the TRUEtrack portable glucometer.
Participants then ingested either GAKIC or PL, and then sat quietly for a 40 min
rest period. This period allowed ample time for the supplement to be absorbed by the
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body’s system. Following this period, another measurement of HR, BLa, and GLU were
performed.
After these measurements had been obtained, the participants warmed up on a
commercial upright stationary bike for 5 minutes. A third measure of HR and BP were
recorded at minute 4 during the 5-minute warm-up period. Participants then completed a
warm-up set on the standard barbell bench press. Participants used a weight of 135
pounds for 8-12 repetitions depending on strength level. Two minutes of rest were
allotted between warm-up sets. One repetition maximum (1-RM) was determined by
increasing weight in 20 to 40 pound increments depending on the participant’s strength
level. One repetition maximum was obtained in 3-6 sets. One RM represents the
maximum weight lifted once with proper form. Immediately following 1-RM
determination, 60% of 1-RM was placed on the bar, while participants rested for 3
minutes. Immediately following the rest period, the participant completed as many
repetitions as possible until failure occurred.
Failure was defined as the inability to complete a full repetition without
assistance. This was used as a measure of muscular endurance. HR, BLa, and GLU were
immediately assessed within 5 seconds of the final repetition. Following a 5-minute rest,
participants warmed-up on the leg press exercise at a load of 200 pounds. Two minutes
of rest were allotted between sets, and 1-RM was determined in 3-6 sets. Immediately
following 1-RM determination, 60% of 1-RM was placed on the leg press, and
participants completed as many repetitions as possible until failure occurred. This bout
served to assess lower body strength and endurance. HR, BLa, and GLU were assessed
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within 5 seconds of the final repetition. The testing time lasted approximately one hour
and twenty-five minutes.

Design
Treatment order (GAKIC or PL) was randomly assigned to participants. A
double-blinded crossover design was used, as neither the principal investigators nor the
participants were aware of the treatment order. Trials were separated by a minimum of 1
week but no more than 2 weeks to minimize participant fatigue.

Dietary and Supplement Intake
Participants completed a 24-hour diet and exercise recall during the 40 min preexercise period of each experimental trial. Participants were also restricted from taking
any medications or supplements 48 hours prior to each trial, and participants were also
asked to abstain from intense exercise within the 48 hours preceding each trial. Those
individuals who failed to acknowledge meeting these criteria during the phone call
preceding the test were rescheduled. Rescheduling was dependent on testing availability
and washout period. All participants complied with the guidelines.

Treatment Ingestion
Over-the-counter GAKIC (manufactured by Muscle Technology; see Appendix
D) or a PL was provided to participants 40 minutes pre-exercise. The amount of GAKIC
ingested by all participants was 11.211.2 grams, in accordance with prior studies that
have used a similar dose (Buford and Koch 2004). Seven days later, participants ingested
18

the other treatment, and repeated the identical exercise protocol. There have been no
reported side effects of GAKIC when taken in recommended amounts by the
manufacturer or cited in prior literature.

Statistical Analysis
Data for lactic acid, glucose, and heart rate were analyzed using two-way repeated
measures analysis of variance ANOVA. Data for one Repetition Max (1RM) and total
load volume (TLV) were analyzed by using a paired-difference t test. An α-priory α <
0.05 was set as statistically significant. The individual data points for lactic acid, glucose,
and heart rate are presented in the graphs, and the mean ± standard deviation is provided
in the text. Furthermore, the 1RM and TLV are presented as box and whiskers
(minimum, lower quartile (Q1), median (Q2), upper quartile (Q3), and maximum) and the
mean ± standard deviation for these measurements is provided in the text. All statistical
analyses were performed by using the GraphPad Prism program (GraphPad Software,
Inc., La Jolla, CA).
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CHAPTER IV
RESULTS

This study consisted of 11 healthy male volunteers (mean age (y) + SD 24.5 ± 4.7,
mean height (m) + SD 1.77 ± 0.11, mean body mass (kg) + SD 88.1 ± 17.7, mean body
fat percentage + SD 13.7 ± 8.1

Heart rate
The heart rates were measured as an indicator of exercise intensity and to
document that participants in both conditions exerted similar effort following both PL
and GAKIC supplementation. Before participants performed the bench press exercise
bout, there were no statistical significant differences (p > 0.05) between PL (72.1 ± 11.9
bpm) and GAKIC (68.1 ± 10.0 bpm). Following the bench press exercise bout, heart rate
increased significantly (p < 0.05) in both conditions (PL: 123.8 ± 15.0 bpm; GAKIC:
121.2 ± 13.6 bpm) but it was not statistically different (p > 0.05) between conditions
(Figure 1). Similar results were obtained when the participants performed the lower body
exercise bout. The heart rate of both the PL and GAKIC conditions were significantly
increased (p < 0.05) following the leg press exercise (PL: 135.2 ± 11.7 bpm; GAKIC:
137.5 ± 18.7 bpm), but HR was not statistically different (p > 0.05) between the
conditions (Figure 1).
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Lactic acid
Blood lactic acid was also measured as an indicator of exercise intensity and to
determine whether GAKIC supplementation had an effect in energy metabolism during
both upper and lower body skeletal muscle exertion. Before the participants performed
the upper body exercise bout, there were no statistical significant differences (p > 0.05)
between PL (2.1 ± 0.6 mmol/l) and GAKIC (2.0 ± 0.9 mmol/l). Following the bench
press exercise bout, blood lactic increased significantly (p < 0.05) in both conditions (PL:
6.0 ± 1.5 mmol/l; GAKIC: 6.5 ± 2.2 mmol/l) but the differences were not significant
between the conditions (Figure 2). Similar results were obtained when the participants
performed the lower body exercise bout. The blood lactic acid of both the PL and GAKIC
conditions were significantly increased (p < 0.05) following leg press exercise (PL: 7.2 ±
2.9 mmol/l; GAKIC: 8.8 ± 1.9 mmol/l), but these were not statistically different (p >
0.05) between the conditions (Figure 2).

Blood glucose
There were no significant differences between the PL or GAKIC conditions in the
pre-exercise blood glucose levels (PL: 100.9 ± 11.211.2 mg/dl; GAKIC: 96.5 ± 8.2
mg/dl). Also, plasma glucose levels did not change significantly following upper body
resistance exercise (PL: 92.1 ± 8.6 mg/dl; GAKIC: 95.5 ± 13.0 mg/dl) or lower body
exercise (i.e. PL: 92.9 ± 7.2 mg/dl; GAKIC: 95.8 ± 14.3 mg/dl) (Figure 3).
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Muscular Strength and Endurance
Muscular strength and endurance were measured in both the upper and lower
body. Specifically, upper body strength was measured by using a 1RM on the bench
press, and lower body muscular strength was measured by 1RM on the leg press.
Muscular endurance was determined by calculating the total load volume (TLV). The
TLV was calculated by multiplying the number of repetitions performed at 60% 1RM by
the number of repetitions to failure. Muscular endurance was determined in both the
upper and lower body by using the bench press and leg press, respectively.
There was no difference in the muscular strength or endurance in the upper body
as measured by the bench press. The PL group had a 1RM of 124.5 ± 25.9 kg where as
the GAKIC group had a 1RM of 126.3 ± 24.3 kg (p > 0.05) (Figure 4). Also, no
significance difference (p > 0.05) in upper body muscular endurance was detected
between the PL and GAKIC conditions (1682.3 ± 354.7 kg vs. 1683.1 ± 409.4 kg in the
PL and GAKIC conditions respectively) (Figure 4).
In contrast to the upper body results, we observed a significant increase in the
lower body 1RM (i.e. muscle strength) following GAKIC supplementation. Specifically,
the 1RM of the GAKIC group was 351.3 ± 46.7 kg and this was significantly higher (p <
0.05) compared to the PL group (327.5 ± 46.7 kg) (Figure 5). The muscular endurance
results of the lower body show a similar trend to the data of lower body muscular
endurance. That is, the TLV showed a trend (p < 0.09) towards an increase in the GAKIC
group (5410.7 ± 847.4 kg) compared to the PL group (4998.0 ± 937.0 kg) (Figure 5).
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Figure 1.

Heart rate (beats per minute; bpm) in subjects performing bench press (upper
body) and leg press (lower body) exercise bouts.

* indicates p < 0.05 between pre and post exercise.
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Figure 2.

Blood lactic acid (mmol/l) in subjects performing bench press (upper body)
and leg press (lower body) exercise bouts.

* indicates p < 0.05 between pre and post exercise.
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Figure 3.

Blood glucose (mg/dl) in subjects performing bench press (upper body) and
leg press (lower body) exercise bouts.

No significant differences were detected between conditions.
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Figure 4.

Upper body strength was measured by using the 1 repetition maximum
(1RM) on bench press. Muscular endurance was determined by calculating
the total load volume (TLV = number of repetitions performed at 60% of the
1RM multiplied by the number of repetitions to failure).

No significant differences were detected (p > 0.05) between conditions.
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Figure 5.

Lower body strength was measured by using the 1 repetition maximum
(1RM) on leg press. Muscular endurance was determined by calculating the
total load volume (TLV = number of repetitions performed at 60% of the
1RM multiplied by the number of repetitions to failure).

* Indicates p < 0.05 between PL and GAKIC. $ p < 0.09 between PL and GAKIC.
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CHAPTER V
DISCUSSION

The major finding in this study was that the participants, when ingesting GAKIC,
showed significant strength gains in the 1RM leg press exercise, with a developing trend
of improvement in the relative maximum endurance portion of the leg press exercise. In
an attempt to form a conclusion to this research, each variable and their data points were
reviewed.

Heart Rate
During exercise, heart rate tends to show linear increases due to increased oxygen
demand from the active skeletal muscles (Myers and Gullestad 1998). Therefore, heart
rate is a sound indicator of participant exertion during this protocol. Exercise intensity is
based from a participant’s percentage of heart rate maximum achieved (McArdle et al.
2007). With the mean age of the participants 24 years of age, and age calculated average
maximum heart rate of 196 bpm, the intensity of the TLV portion of the upper body
protocol was very moderate (63% for the PL, and 62% for the GAKIC). The lower body
TLV intensity was slightly, but expectantly increased with 69% with the PL and 70%
with the GAKIC. Lowered resistance with increased sets and repetitions yields high
intensity, resistance exercise. It was not expected for the participants to average
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substantially increased heart rates, but the increased rates indicate the intensity and the
effort given towards the specific exercise. With resting heart rates showing no significant
differences between PL and GAKIC, it can be assumed that GAKIC contained no
stimulants such as caffeine, which is used in GAKIC’s newest form GAKIC
HARDCORE.

Blood Lactate
Lactate is constantly produced in humans at both rest or during exercise. It is
derived from pyruvate via the enzyme lactate dehydrogenase (Brooks 2009). The
accumulation of blood lactate in the blood indicates increasing anaerobic metabolic
processes, coupled with the inability to maintain a removal rate at or below the level of
production (Donovan and Brooks 1983). While blood lactate levels can be used as an
indicator of exercise progression, it is important to note that increased lactate levels can
also indicate metabolic disorders such as diabetes, which produces high blood lactate
levels due to the lack of ability to break down glucose for energy, thus using anaerobic
pathways for energy. Blood lactate measures are recorded in mm/dl, with typical resting
values ranging between .08 and 1.9. Any resting values over such would indicate very
recent exercise and/or exertion. Blood lactate values increased respectively during
exercise, indicating progression and exertion. With no significant differences in blood
lactate, it can be hypothesized that GAKIC does not buffer lactic acid.
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Blood Glucose
Glucose is a simple sugar, combustible by oxygen, which is used in the
production of ATP (Simoes et al. 1999). During exercise, muscle receptors stimulate the
release of insulin to uptake glucose to be used for energy (Simoes et al. 1999). The
significant differences not found in blood glucose level can be contributed to the
abundance of its molecules throughout the body via blood glucose or glycogen stores in
the liver (Simoes et al. 1999). Studies have shown that it takes a heavily prolonged bout
of exercise to deplete the body of glucose (Ahlborg et al. 1974). With the exercise
paradigm chosen for this research, it was unlikely to see significant decreases in glucose
due to the duration of the series of exercise bouts. With there being no significant
increases in blood glucose, this suggests that GAKIC did not act as a simple sugar or
glucose precursor.

Upper Body 1RM and TLV
In this study both a lower and an upper body exercise paradigm was employed. In
contrast to the leg press exercise, the bench press uses an isolated group of muscles, in
which a majority of those muscles are used as stabilizers (pectoralis major, anterior
deltoids, serratus anterior, coracobrachialis, scapula fixers, trapezii, and triceps) (Ratel et
al. 2006). Muscles utilize anaerobic metabolism via the ATP PCr pathway for single,
maximum bouts as well as short duration bouts (Macedo et al. 2009). To produce
maximum strength and maintain muscular endurance, this system must recover over a
relatively short period of time; however, during the duration of a prolonged workout,
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these muscle stores of phosphocreatine are depleted, causing the body to revert to aerobic
pathways (Westerblad et al. 2006).
People tend to train to failure on the bench press due to the aid of a spot,
decreasing the chance of the bar falling on them due to fatigue. With TLV being directly
related to the 1RM max, it would be safe to say that if significant differences were not
found with 1RM, chances are that significant differences would not be found in the TLV.
In special cases, such as the use of creatine supplementation, and increased TLV without
an increase in 1RM can be seen due to the increase of phosphocreatine store and the
system utilized (ATP PCr).

Lower Body 1RM and TLV
Lower body muscle groups are larger and require more blood and oxygen to do
work which can fatigue a person more expeditiously compared to an upper body exercise
(quadriceps, gluteals, and calves) (Rawson, 2010). These muscles also contain substantial
amounts of myoglobin, found predominantly in type IIb, fast twitch anaerobic muscles
(Arany et al. 2006). Contrary to the upper body 1RM results, there was a significant
difference in lower body maximum strength between the GAKIC and PL conditions,
which was indicated by a 7.3% increase in mean lower body maximum strength between
conditions.
These results suggest the supplement could have a certain activation threshold,
meaning a certain amount of work must be completed to activate the effects of GAKIC.
GAKIC’s improvements can be directed towards improving the ATP PCr system, the
primary system utilized in this protocol.
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Perception of pain is a determinate of when a person decides they are fatigue from
an exercise. The TLV portion was designed for participants to experience as well as push
through pain until failure. With the results of the lower body TLV portion following a
similar trend to lower body 1RM, it is indicated that GAKIC may have a positive effect
on ATP PCr recovery and mitigate the subjects’ perception of pain.

Conclusion
In conclusion, having employed a specific protocol to demonstrate its effects,
GAKIC treatment, compared to a PL control, demonstrated an improvement in maximum
strength in the leg press exercise with lower body TLV following a similar trend.
GAKIC, however, did not seem improve maximum strength or muscular endurance in the
bench press exercise. In comparing demographical data sets, and procedures against the
previous studies, it was noticed that studies concluding GAKIC improvements were
closely related when looking at body mass and dosage of supplement. Bies et. Al.
concluded that in contrast to the untrained participants in the previous studies, that
GAKIC had no effect on the well trained cyclist. Those cyclists were on average at least
10kg lighter and 9 years older than the participants in this, and the other two studies. The
differences not found in their study could have been contributed to the years of intense
training and adaptations compared to the participant in this and the other two studies This
study, in contrast to the previous three, utilized GAKIC in its pill for instead of a
dissolved powder. This could have negated some of the performance gains seen in Buford
and Koch and Steven et al. studies due to time and effectiveness of digestion. With the
underlying mechanism of GAKIC not being clear, it could assumed that GAKIC may
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serve as a recovery aid, promoting more attempted reps, which can cause significant
gains in overall maximum strength and endurance. This protocol was performed with two
observations per participant separated by one week of recovery/washout, which caused a
limited amount of observation. With further research encouraged, GAKIC’s effect on
prolonged exercise bouts, such as circuit training would also be research topics.
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